SMTL ID : 3l9l.1 (1 other biounit)

Crystal structure of pka with compound 36

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

hetero-oligomer

Ligands

1 x L9L: 5-[2-({(2S)-2-AMINO-3-[4-(TRIFLUOROMETHYL)PHENYL]PROPYL}AMINO)-1,3-THIAZOL-5-YL]-1,3-DIHYDRO-2H-INDOL-2-ONE(Non-covalent)

L9L.1: 17 residues within 4Å: Chain A: L.50, G.51, F.55, V.58, A.71, K.73, M.121, E.122, Y.123, V.124, E.128, E.171, N.172, L.174, T.184, D.185, F.328 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:F.55, A:V.58, A:A.71, A:M.121, A:L.174, A:T.184 Hydrogen bonds: A:E.122, A:V.124, A:D.185, A:D.185, A:D.185 Water bridges: A:K.169

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zeng, Q. et al., Azole-based inhibitors of AKT/PKB for the treatment of cancer. Bioorg.Med.Chem.Lett. (2010)

Release Date

2011-01-19

Peptides

cAMP-dependent protein kinase catalytic subunit alpha: A
cAMP-dependent protein kinase inhibitor alpha: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

cAMP-dependent protein kinase catalytic subunit alpha

cAMP-dependent protein kinase inhibitor alpha

Related Entries With Identical Sequence